News

Oceaneering International, Inc. (“Oceaneering”) (NYSE:OII) announces that it will report financial results for the second quarter of 2025 on Wednesday, July 23, 2025, after the close of trading on

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on July 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement

Broadstone Net Lease, Inc. (NYSE: BNL) (“Broadstone,” “BNL,” the “Company,” “we,” “our,” or “us”), today announced that it will release its financial and operating results for the quarter ended

Dyadic International, Inc. (“Dyadic”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered input proteins for non-therapeutic

Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement that creates and distributes world-class content, training, processes, and tools that organizations and individuals

Energy services provider Expro Group Holdings N.V. (NYSE: XPRO) (the “Company”) today announced that effective June 30, 2025, the Compensation Committee of its Board of Directors granted equity

GrafTech International Ltd. (NYSE:EAF) (the “Company”) will hold its Second Quarter 2025 Earnings Conference Call and Webcast on Friday, July 25, 2025 at 10:00 a.m. (EDT). The call will be hosted

BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced it will release second quarter 2025 financial results on Tuesday, July 29, 2025, after the market

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 119,860

Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector

Humana Healthy Horizons is now a Medicaid plan option for Virginians covered by Virginia Cardinal Care.

“At Humana, we put our members’ health first, and we are committed to improving the

Regulatory News:

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies^TM (MET) dedicated to

ServiceNow (NYSE: NOW) today announced that it will release financial results for the second quarter ended June 30, 2025, following the close of market on Wednesday, July 23, 2025. ServiceNow will

Martin Midstream Partners L.P. (NASDAQ: MMLP) (“MMLP”) will announce its financial results for the second quarter 2025 on Wednesday, July 16, 2025, after the market closes where it can be accessed

North American automotive and mobility companies are investing in transformations of their products and operations in response to significant changes in technology, consumer demand and regulation

In line with its renewables business model, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces the completion of the sale of 50% of its 604 MW wind, solar and hydro portfolio in Portugal to

TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces the closing of its acquisition of a 50% stake in the solar, wind and Battery Energy Storage Systems (BESS) portfolio of AES Dominicana